Overview


According to FutureWise analysis the market for ambulatory infusion center is expected to register a CAGR of 8.90% from 2023-2031.

An Ambulatory Infusion Center (AIC) is an alternative care site to a home, physician's office, or hospital setting, where patients can receive infusion treatment of specialty drugs in safe, monitored surroundings. Care is taken by skilled nurses and clinical pharmacists according to physician's orders. Infusion therapy involves the administration of medications, fluids, blood derivatives, or other therapeutic implications directly into a patient's bloodstream through a vein. It delivers various treatments, including chemotherapy, antibiotic therapy, pain management, biological therapies, immunoglobulin infusions, and hydration. The purpose of an Ambulatory Infusion Center is to provide comfortable and convenient surroundings for patients who require ongoing infusion therapy but do not need to be hospitalized. By offering outpatient services, AICs help patients avoid lengthy hospital stays and allow them to receive treatment in a more relaxed and less clinical environment.

Managing infusion therapies needs specialized facilities and expertise. The infusion drugstore must ensure that the infusion drugs are compounded in sterile conditions by maintaining an environment conducive to keeping drugs sterile and steady and ensuring the suitability of vascular access sites based on pH, the osmolality of medications, osmolarity, and the duration of therapy. Prescriptions should be administered with the proper drug-delivery device and washed with the appropriate solutions between doses. Infusion druggists are also responsible for identifying potential drug, drug dose, or drug–catheter incompatibilities.

FutureWise Market Research has published a report that provides an insightful ambulatory infusion center market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, ambulatory infusion center market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • PharmaScript
  • Hattiesburg Clinic
  • CHI Health
  • IVX Health
  • Accredo Health
  • Cleveland Clinic
  • HCA Healthcare
  • Option Care Health
  • Premier Point
  • Owensboro Health
  • Dixie Vital Care
  • ChristianaCare
  • Oso Home Care Inc.
  • Stoughton Health
  • Coram CVS
  • UnitedHealth Group
  • UK HealthCare
  • PharMerica
  • Beacon Health System, Inc.
  • Arnot Health, Inc.
  • Precision Healthcare

(Note: The list of the major players will be updated with the latest market scenario and trends)

The growing incidences of chronic disease such as cancer, autoimmune disorders, and infectious diseases is expected to fuel the demand for the ambulatory infusion center market. The global senior population is growing, and the incidence of chronic disease is rising. Older adults are more susceptible to these disorders, and the demand for ambulatory infusion centers is increasing for ongoing treatments and management options. Also, the increasing prevalence of outpatient care over hospitalization is driven by cost-effectiveness, reduced risk of hospital-acquired infections, and improved patient convenience. Ambulatory infusion centers provide a viable alternative for patients who require regular infusion therapies, allowing them to receive treatment in a comfortable and less disruptive setting. However, strict regulations and the need for skilled professionals will likely hinder the market's growth in the forecast period. Ambulatory infusion centers are subject to strict regulatory conditions to ensure patient safety and quality of care with the healthcare standards. These regulations may differ across regions and implicate licensing, accreditation, and compliance with specific protocols. The successful operation of ambulatory infusion centers relies on a skilled workforce, including nurses, physicians, pharmacists, and support staff. However, there is a need for more healthcare professionals with expertise in ambulatory care and infusion therapy. The need for more skilled professionals can limit the capacity and expansion of ambulatory infusion centers. Moreover, the shift towards personalized medicines and targeted therapies creates an excellent opportunity for the ambulatory infusion market. The area of precision medicine is rapidly evolving with advancements in genomics and molecular diagnostics and delivering targeted therapies to each individual with particular characteristics.

By Therapy Type

  • Blood Product Infusion
  • Iron Therapy
  • Steroid Infusion
  • Immunoglobulin Therapy
  • Therapeutic Phlebotomy
  • Plasmapheresis
  • Clotting Factor Replacement Therapy
  • Other Therapy Types

By Application

  • Chronic Inflammatory Disorders
  • Neurological Disorders
  • Cancers
  • Nutrition Support
  • Gastro-intestinal Disorders

By Distribution Channel

  • Hospital
  • Clinic
  • Home Infusion

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is attributed to the expansion of service facilities for ambulatory infusion centers, which will likely drive the growing market of the benefits they provide in diagnosing and treating various diseases, including chronic diseases and cancer. Also, different companies are focusing on organic growth strategies such as product launches and approvals, which are further driving market growth. Therefore, the above-mentioned factors are expected to propel the market growth over the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Ambulatory Infusion Center Market By Therapy Type, By Application, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Ambulatory Infusion Center Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Ambulatory Infusion Center Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Ambulatory Infusion Center Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Ambulatory Infusion Center Market, By Therapy Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Blood Product Infusion
        2. Iron Therapy
        3. Steroid Infusion
        4. Immunoglobulin Therapy
        5. Therapeutic Phlebotomy
        6. Plasmapheresis
        7. Clotting Factor Replacement Therapy
        8. Other Therapy Types

  • 8.   Ambulatory Infusion Center Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Chronic Inflammatory Disorders
        2. Neurological Disorders
        3. Cancers
        4. Nutrition Support
        5. Gastro-intestinal Disorders

  • 9.  Ambulatory Infusion Center Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
      1. Hospital
      2. Clinic
      3. Home Infusion
  • 10.   North America Ambulatory Infusion Center Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Ambulatory Infusion Center Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Ambulatory Infusion Center Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Ambulatory Infusion Center Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. PharmaScript
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Hattiesburg Clinic
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. CHI Health
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. IVX Health
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Accredo Health
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Cleveland Clinic
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. HCA Healthcare
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Option Care Health
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Premier Point
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Owensboro Health
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Dixie Vital Care
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. ChristianaCare
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Oso Home Care Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Stoughton Health
                 14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Coram CVS
                 15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. UnitedHealth Group
                 16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. UK HealthCare
                 17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. PharMerica
                 18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Beacon Health System, Inc.
                 19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Arnot Health, Inc.
                 20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21. Precision Healthcare
                 21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients